{"id":"W2886255359","doi":"10.1200/jco.2017.35.15_suppl.5518","title":"Adverse events (AEs) with maintenance olaparib tablets in patients (pts) with <i>BRCA</i>-mutated (<i>BRCA</i>m) platinum-sensitive relapsed serous ovarian cancer (PSR SOC): Phase III SOLO2 trial.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Olaparib; Medicine; Nausea; Discontinuation; Vomiting; Internal medicine; Adverse effect; Tolerability; Anemia; Oncology; Neutropenia; BRCA mutation; Gastroenterology; Chemotherapy; Ovarian cancer; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009549418,0.0005127728,0.0007661895,0.0001893764,0.0001627499,0.0004691399,0.0003549324,0.0004319559,0.002006777],"category_scores_gemma":[0.0006649528,0.0002082064,0.00116806,0.000377807,0.000256567,0.0003223376,0.0002246639,0.0009565226,0.0001511944],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000555223,"about_ca_system_score_gemma":0.0004995698,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004312696,"about_ca_topic_score_gemma":0.001383608,"domain_scores_codex":[0.999696,0.0001438309,0.00002966486,0.00005548958,0.00004308939,0.00003182025],"domain_scores_gemma":[0.9994724,0.0001186898,0.0002586904,0.00002263485,0.00001856077,0.0001090049],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7393786,0.00710419,0.08058424,0.003154579,0.004927749,0.0004253722,0.0002025807,0.002214901,0.02214099,0.0001448892,0.003595916,0.136126],"study_design_scores_gemma":[0.4238434,0.3370663,0.2161047,0.0002964237,0.004835116,0.001986749,0.0001352752,0.003440107,0.006473467,0.0002824565,0.005478157,0.00005799713],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944625,0.003675352,0.0001516099,0.0001031658,0.0000181014,0.000357308,0.000655461,0.00001744578,0.000558978],"genre_scores_gemma":[0.995859,0.001468279,0.0003530495,0.0001740911,0.00005139507,0.0003835204,0.001297084,0.000003985061,0.0004095719],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002006777,"threshold_uncertainty_score":0.006713331,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07173639697451109,"score_gpt":0.4348203187221891,"score_spread":0.363083921747678,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}